Clinical Trial

Clofutriben Pharmacokinetics in Patients With Impaired Renal Function

Study acronym: RENAL
Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated December 23, 2025 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a Phase 1, single-center, open-label, single-dose trial. Sixteen participants are planned: 8 participants with moderate renal impairment and 8 matched control participants with normal renal function.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-11; most recent amendment 2025-12-22.
Status change: Not Yet Recruiting → Recruiting 2025-11-19
Trial Details
NCT Number NCT07227922
Lead Sponsor Sparrow Pharmaceuticals
Conditions Moderate Renal Impairment
Enrollment 16 participants
Start Date 2025-11-30
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-23